Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Radiologist who drove his family off a cliff cleared to leave jail

The doctor was previously charged with three counts of attempted murder—one for each of the passengers in the vehicle when he sent it plunging off a 250-foot cliff.

FDA warning alert exclamation computer

FDA issues update on MRI coil recall

In May, Philips alerted its customers to the safety concern, cautioning that its Sense XL Torso (1.5T and 3T) coils could overheat and cause patients to sustain serious burns.

Thumbnail

Former smokers who vape now still need to be screened for lung cancer. Many of them aren't

Despite kicking their initial habit, these individuals remain at risk of developing lung cancer due to their history of smoking cigarettes, current use of e-cigarettes, or both, experts caution.

Thumbnail

MRI safety concerns prompt FDA to issue recall for series of ventilators

The Class I recall affects the ZOLL 731 Series Ventilator family, including the AEV, EMV+, and Eagle II models.

Philips Zenition 90 Motorized mobile C-arm with flat detector

Philips’s new motorized C-arm earns FDA clearance

The motorized component removes the need for manual positioning adjustments during procedures, improving both accuracy and efficiency.

Thumbnail

Radiologist who tried to cover up multiple procedural mistakes is handed a career-ending judgment

There were two serious incidents in the span of three months that raised concerns among the radiologist's colleagues, according to official documents. 

Thumbnail

New Drug Application for PSMA-PET 'cold kit' could expand access to prostate imaging

If approved, the kit could allow for more flexible production of prostate cancer imaging agents.

the words "FDA recall" on a board

Dozens of injuries trigger FDA recall of over 50,000 implantable tissue marking devices

The Class I recall, which is the most serious recall the FDA issues, comes after numerous adverse events and complications linked to the radiographic markers were reported.  

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.